Cyclosporin a for the treatment of systemic lupus erythematosus
- 1 January 1981
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 3 (2), 163-169
- https://doi.org/10.1016/0192-0561(81)90007-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Use of cyclosporin A in allogeneic bone marrow transplantation in the ratNature, 1979
- Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in manNature, 1979
- IMMUNE COMPLEXES IN OVARIAN CANCERThe Lancet, 1978
- EXTENSIVE PROLONGATION OF RABBIT KIDNEY ALLOGRAFT SURVIVAL AFTER SHORT-TERM CYCLOSPORIN-A TREATMENTThe Lancet, 1978
- Characterization of a Suppressor-Cell LeukemiaNew England Journal of Medicine, 1978
- Suppressor T-cell abnormality in idiopathic systemic lupus erythematosusClinical Immunology and Immunopathology, 1976
- Detection of Antibodies and Soluble Antigen-Antibody Complexes by Precipitation with Polyethylene GlycolThe Journal of Immunology, 1973
- Hereditary angio‐oedema: a review with particular reference to pathogenesis and treatmentClinical and Experimental Allergy, 1971